In the present study, in an effort to further understand the role of Bregs in the etiology and pathogenesis of breast cancer, we examined CD4+ T cells, CD19+ B cells and their subsets in PBMCs of breast tumor patients, and investigated the relationship among CD4+ T cells, CD19+ B cells and their subsets in breast tumor. This evidence concerns the gene CD19 and breast carcinoma.